Triveni Kothapalli, Author at CatalystPICR

19 POSTS 0 COMMENTS

https://www.catalystpicr.com

Perfect Moment ($PMNT) Q4 EPS Beats Estimates; Revenue Up YoY

Triveni Kothapalli - June 29, 2026 9:00 am

Super League Enterprise ($SLE) Q4 Revenue Declines; EPS Loss Beats Projections

Triveni Kothapalli - March 27, 2026 8:15 am

Autolus ($AUTL) Reports Q4 Revenue Increase; Misses Analyst Estimates

Triveni Kothapalli - March 27, 2026 8:01 am

SBC Medical Group ($SBC) Q4 EPS Beats; Revenue Misses Expectations

Triveni Kothapalli - March 27, 2026 7:20 am

Shoe Carnival ($SCVL) Q4 Revenue Surpasses Expectations

Triveni Kothapalli - March 26, 2026 7:05 am

Enerpac Tool Group’s ($EPAC) Revenue Beats Expectations in Q2 2026

Triveni Kothapalli - March 25, 2026 6:10 pm

DigitalOcean ($DOCN) Prices $800 Million Upsized Stock Offering

Triveni Kothapalli - March 25, 2026 10:50 am

Velo3D ($VELO) Names James Suva as Chief Financial Officer Effective April...

Triveni Kothapalli - March 25, 2026 9:57 am

PDD Holdings ($PDD) Sees Revenue Increase in Q4 2025

Triveni Kothapalli - March 25, 2026 8:25 am

Chewy ($CHWY) Sees Year-Over-Year Revenue Increase in Q4

Triveni Kothapalli - March 25, 2026 8:15 am

12 Page 1 of 2

CATALYST News

Outlook Therapeutics ($OTLK) Secures FDA Approval for LYTENAVA™

NewsDesk - July 24, 2026 3:10 pm

Charter Communications ($CHTR) Beats Q2 EPS Estimates; Revenue Decline Driven by Lower Video Revenue

NewsDesk - July 24, 2026 8:21 am

SLB ($SLB) Q2 performance beats expectations; EBITDA and cash flow robust

Staff Writer - July 24, 2026 8:13 am

Sensient Technologies ($SXT) Beats Q2 EPS and Revenue Estimates; Projects Strong FY26 EPS

NewsDesk - July 24, 2026 8:02 am

American Express ($AXP) Beats EPS Estimates; Revenue Misses Amid Strong YoY Growth

Catalyst Desk - July 24, 2026 8:00 am

American Express ($AXP) Beats EPS Estimates; Revenue Misses Amid Strong YoY Growth

Catalyst Desk - July 24, 2026 8:00 am

FDA Approves MannKind’s ($MNKD) Furoscix ReadyFlow for Heart Failure and CKD

NewsDesk - July 24, 2026 7:25 am

Inhibikase ($IKT) Receives FDA Orphan Drug Designation for IKT-001

Catalyst Desk - July 23, 2026 8:23 am

Tesla ($TSLA) Q2 Earnings Miss Expectations; Revenue Surges YoY

Staff Writer - July 22, 2026 5:36 pm

IBM ($IBM) Exceeds Q2 EPS and Revenue Estimates; Software Revenue Up

NewsDesk - July 22, 2026 5:13 pm